Future Fertility, a healthtech company developing non-invasive AI-based fertility solutions has received CE Mark approval under the new European Union Medical Device Regulation (MDR). The company uses artificial intelligence to analyze 2D images of oocytes and generate personalized, validated insights for egg-freezing and IVF patients. Its tools have been proven through scientific evidence to detect features that are invisible to the human…
Interest in surrogacy has never been higher. For many couples and individuals, surrogacy — a process that can easily cost $125,000 or more per child — is their best option for growing their family. However, the slow-moving and antiquated process can take years, complete with hidden costs and unforeseeable issues that can make the experience incredibly stressful, sometimes heartbreaking and often unattainable.…
Earlier this year Oma Fertility, a company focused on using AI-enabled technology to improve IVF outcomes, announced the opening of its first fertility clinic in California and a $37.5M funding round. At the time the company also shared its plans to build a fertility clinic network in the U.S. and is making the first step in that direction today. Oma Fertility has…
Breast implants are a common cosmetic procedure that involves the placement of implants to enhance the size and shape of the breasts. Many women considering breast implants may have concerns about how it could potentially affect their fertility. In this article, we will explore the relationship between breast implants and fertility to provide a better understanding of the topic. Breast implants, whether…
Apricity, the UK’s leading virtual fertility clinic has raised €17M in Series B funding to support the companies expansion in Europe. The round was led by MTIP, a Swiss healthtech fund with participation from Spain-based consumer fund Iris Ventures. Apricity launched in 2018 in the UK and was originally incubated by Kamet Ventures. The company advocates for a new approach to reproductive…
A first-of-its-kind software platform, Alife Assist™ utilizes data-driven insights and AI to optimize and support clinical decision-making during ovarian stimulation, embryo grading, and overall operations SAN FRANCISCO, October 24, 2022 – Alife Health announced the launch of its Alife Assist™ platform today. This new suite of products aims to help fertility clinics utilize and leverage data-driven insights and artificial intelligence (AI) to…
Global pioneer in fertility science, research and treatment’s breakthrough study nominated for Prize Paper at the 78th Annual ASRM Scientific Congress & Expo ANAHEIM, Calif., Oct. 24, 2022 /PRNewswire/ — In a breakthrough clinical study, CCRM Fertility has identified a subset of gene variants in individuals that can help predict the future onset of premature diminished ovarian reserve (DOR). The predictive DOR risk model developed by CCRM Fertility allows…
New fertility financing option combined with an artificial intelligence-enabled platform and IVF-expert concierge counseling empowers patients with lower and more predictable IVF costs and improved rates of pregnancy and birth. LOS ALTOS, Calif., Oct. 24, 2022 /PRNewswire/ — Univfy®, an AI platform company whose mission is to make in vitro fertilization (IVF) accessible, announced today a new financing program that marries Univfy’s artificial intelligence with…
